News

BRAVƎ consortium general meeting in Würzburg, Germany October 2024, Würzburg (Germany). The BRAVƎ project held its Annual Meeting 2024 the 29th and 30th of October in Würzburg, Germany. UKW, with the support of UNAV, organized an in-person two-days meeting to discuss the latest progress of the project. During the meeting, all beneficiaries exposed the evolution of their teamwork in [...]

BRAVƎ consortium present at Biofrabication 2024, Fukuoka, Japan November 2024. Some partners from BRAVƎ have participated in the prestigious International Congress on Biomaterials (https://www.biofabrication2024.org/) held in Fukuoka, Japan, where they presented their latest scientific advancements in the field of biomaterials. The event, which attracted leading researchers, industry experts, and academic professionals from around the globe, provided a unique platform [...]

The European Commission has granted a six-month extension to BRAVƎ October 2024, Pamplona (Spain). The European Commission has approved a six-month extension to the BRAV3 project in order to further explore its key areas of investigation. With this extension, the project which started the 1st of January of 2020 will ends the next 30th of June of 2025, allowing [...]

Major Milestone in Dissemination and Communication Efforts. September, 2024, Pamplona (Spain). The BRAVƎ project, a groundbreaking initiative focused on cardiovascular diseases, has achieved a significant milestone in its dissemination and communication efforts. The project team has successfully engaged a wide range of audiences, including policymakers, academics, clinicians, researchers, industry leaders, patient association’s and the general public, to share key [...]

BRAVE project researchers from Cima Universidad de Navarra have designed a computational model that, for the first time, can simulate the behavior of artificial cardiac tissue. This novel tool will make it possible to accelerate the manufacture of human myocardium in the laboratory. October 25, 2022, Pamplona (Spain). Researchers at Cima Universidad de Navarra have developed a system that, [...]

Ethics of Early Clinical Trials of Bio-Artificial Organs - The article is a summary of the international meeting "Ethics of Early Clinical Trials of Bio-Artificial Organs" held in February July 2022. Organ Transplantation, the official scientific journal of the European Society for Organ Transplantation, publishes in its latest issue a meeting report of the international workshop held online in February [...]

­­­­­­Ethics of the first clinical trials in regenerative medicine for transplantation The BRAVƎ project will participate in an international workshop on the challenges of new applications in bioengineering and regenerative medicine that are reaching the clinic. The BRAVƎ project will participate in an international workshop to discuss the challenges of new applications in bioengineering and regenerative medicine that are [...]

BRAVƎ partners will meet to share project progress and to specify the following objectives in the BioVAD creation The meeting will take place at the University of Navarra (Pamplona- Spain) November 2021. The BRAVƎ project is holding its Annual Meeting 2021 this Tuesday and Wednesday, November 23th and 24th. After a first year marked by the pandemia, this second call [...]

Cima Universidad de Navarra and Clínica Universidad de Navarra organize a medical symposium on the challenges and latest bioengineering and technological advances applied to healthcare November 2021. On November 18th, the BRAVE project will participate in the medical symposium "Leading-edge Regenerative Medicine," an international event aimed at researchers, students, and professionals in the biomedical and technological sector applied to [...]

“BRAVƎ’s greatest challenge is to demonstrate the translational capacity of tissue engineering to clinical practice in the cardiac area” BRAVƎ External Advisory Board member Dr Elena de Juan shares her views on the project On February 5th BRAVƎ project celebrated its first External Advisory Board Meeting. It was an opportunity for the project leaders to share with a group [...]

BRAVƎ held its first External Advisory Board Meeting where the experts noted the importance to keep the translation of the BIOVAD in mind and highlighted the successes achieved during the first year of the project, despite the pandemic February 2021. BRAVƎ project celebrated its first External Advisory Board Meeting where all work package leaders presented their work and progress [...]

Pamplona (Spain), November 19th, 2020.The European consortium held its annual meeting to assess the difficulties and successes of this first year coinciding with the global pandemic. On November 19th and 20th, the BRAVƎ cardiac regeneration project held its first annual meeting organized by the Clínica Universidad de Navarra. The conference brought together representatives of the 14 European institutions that [...]

An international study linked to the BRAV3 project showed the molecular mechanisms involved in the activation of these cardiac fibroblast in the presence of cardiac damage and the fundamental role of the CTHTC1 protein in the restorative process Pamplona (Spain), September 29th, 2020. An international study linked to the BRAVƎ project has identified the cardiac cells responsible for repairing the [...]

This European research led by Clínica Universidad de Navarra seeks to recover the functionality of an infarcted heart by combining bioengineering and cardiac stem cells. "Campus Vivo" is the name of the national exhibition on university research of which BRAVƎ is a part. Pamplona, July 16, 2020. BRAVƎ is a European cardiac regeneration project led by Clínica Universidad de Navarra [...]

This cardiac regeneration research gathered the European consortium partners to establish the project foundations January 30th (Spain). The BRAVꓱ project started with its kick-off meeting held on January 27th-29th at the Clínica Universidad de Navarra's Madrid (Spain) headquarters. BRAVꓱ is an ambitious project whose objective is to design and create a biological device to support a sick heart. It aims to recover the [...]

Engineering a biological device to support a sick heart The BRAVƎ project, which is funded by the European Commission, combines cell therapy and bioengineering to design a biological device that recovers cardiac functionality in people with cardiovascular disease. Cardiovascular disease is the leading cause of death in the world Spain, October 29th, 2019. BRAVƎ project is an international research initiative [...]